Exploring the Mechanism and Suggesting Combination Therapies for HDAC Inhibitors in Androgen Receptor-Null Prostate Cancer Using Multivariate Statistical Analysis and Data Mining Techniques

Previously, we showed that novel histone deacetylase (HDAC) inhibitors, N1-hydroxy-N(8)-(4-(pyridine-2-carbothioamido)phenyl)octanediamide (Jazz90) and [chlorido(η(5)-pentamethylcyclopentadienyl)(N1-hydroxy-N8-(4-(pyridine-2-carbothioamido-κ(2)N, S)phenyl)octanediamide)rhodium(III)] chloride (Jazz16...

Descripción completa

Detalles Bibliográficos
Autores principales: Rana, Zohaib, Rosengren, Rhonda J, Smith, Paul F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772946/
https://www.ncbi.nlm.nih.gov/pubmed/36570326
http://dx.doi.org/10.1177/11779322221145428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772946/
https://www.ncbi.nlm.nih.gov/pubmed/36570326
http://dx.doi.org/10.1177/11779322221145428

Ejemplares similares